ArticleJournal of molecular modeling2025
The structural view of the protein PGD-219aa encoded by the circular RNA CircPGD.
Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Circular RNAs (circRNAs), belonging to the class of non-coding RNA molecules, have emerged as one of the key regulators of gene expression. Some of the circRNAs have proven protein-coding potentials, and their gene products play significant roles in various physiological and pathological processes. One such protein is PGD-219aa, which is derived from the circRNA named CircPGD. The protein has been shown to regulate the SMAD3 and YAP signalling pathways in gastric cancer. However, only the amino acid sequence of the protein is available to date without any reports on its structure-function relationships. Therefore, we used computational methods to characterise the protein and decipher its functional roles. Furthermore, we performed pathway analyses to shed light on the biochemical avenues where the protein might have a significant presence. From our analyses, we could point towards the importance of a key amino acid residue, Ser177, which might have fundamental functional roles. Future studies might involve targeting this particular amino acid to delineate its functional characteristics. Subsequently, we could propose the association of the protein not only to gastric cancer but also with other diseases as well. Through this work, we tried to analyse the plausible details of the functional roles of the protein. Our work may help in future drug development endeavours to combat the spread of gastric cancer tumours. CONTEXT: Circular RNAs (circRNAs), belonging to the class of non-coding RNA molecules, have emerged as one of the key regulators of gene expression. Some of the circRNAs have proven protein-coding potentials, and their gene products play significant roles in various physiological and pathological processes. One such protein is PGD-219aa, which is derived from the circRNA named CircPGD. The protein has been shown to regulate the SMAD3 and YAP signalling pathways in gastric cancer. However, only the amino acid sequence of the protein is available to date without any reports on its structure-function relationships. From our analyses, we could point towards the importance of a key amino acid residue, Ser177, which might have fundamental functional roles. Future studies might involve targeting this particular amino acid to delineate its functional characteristics. Subsequently, we could propose the association of the protein not only to gastric cancer but also with other diseases as well. Through this work, we tried to analyse the plausible details of the functional roles of the protein. Our work may help in future drug development endeavours to combat the spread of gastric cancer tumours.
methodsTherefore, we used computational methods to characterise the protein and decipher its functional roles. Furthermore, we performed pathway analyses to shed light on the biochemical avenues where the protein might have a significant presence.
Indexed as
Identifiers
40782249What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.